EUVIMED · CrossrefJournal
JNCI: Journal of the National Cancer Institute
ISSN 0027-8874 · Oxford University Press (OUP)
Latest articles
RE: Matched Targeted Therapy Use after Broad Genomic Profiling in Advanced Non-Small Cell Lung Cancer
Response to Sun, Zang, & Chen
Genomic ascertainment of PALB2 -related cancer predisposition
Immune protection against anogenital HPV in Rwandan women with and without HIV following the introduction of quadrivalent HPV vaccination
Health-related quality of life in patients with solid cancer treated with immune checkpoint inhibitors: the ARON-MOUSEION-18 systematic review and meta-analysis
Estimates of breast cancer screening benefit in older women to inform patient-centered care
Eligibility and real-world use of adjuvant chemotherapy in colon cancer: a Dutch nationwide study
RE: Alcohol Consumption and Colorectal Cancer Risk in Prediabetes and Diabetes: A Nationwide Cohort Study
Re: Alcohol consumption and colorectal cancer risk in prediabetes and diabetes: a nationwide cohort study
Response to Manrique-Hernández, Hurtado-Ortiz, and Licht-Ardila and to Liao, Wong, and Lai
New diagnostic criteria can inflate myelodysplastic syndrome survival estimates
RE: SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis
Response to Mokbel and Mokbel: SHBG and breast cancer risk in premenopausal women
Cross-ancestry proteome-wide mendelian randomization of plasma proteins and breast cancer susceptibility
Home-Built environment as medicine for long-term cancer survivorship: a hard pill to prescribe
Olanzapine or prochlorperazine added to antiemetic therapy for persistent chemotherapy-induced nausea: an NCORP phase 3 RCT
Operationalizing smoking cessation models of care in oncology settings: a mixed-methods systematic review
Geographic variation In Long-Term PM2.5 exposure and lung cancer incidence in the United States
Correction to: Impact of KRAS codon-specific mutations on survival in metastatic CRC on trifluridine-tipiracil with/without bevacizumab
Correction to: Breast implant illness after reconstruction with silicone breast implants
Pretreatment cognitive screening, treatment tolerability, and early mortality in older adults with advanced cancer initiating systemic therapy
Occupational solar ultraviolet radiation exposure and incident ocular melanoma risk in two large-scale nordic cohorts
US geographical disparities in young-onset colorectal cancer mortality, 1990–2023
Advancing gastric cancer prevention in the United States: perspectives from a congressional forum
The ethical dilemma of excluding patients from clinical trials based on language preference
The risk of gastric mucosa-associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication treatment
Treatment-related neutropenia as predictor of response to adjuvant palbociclib in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
Pragmatic Trials Funded by the National Cancer Institute, 2009-2023: A Portfolio Analysis
Modeling neoadjuvant treatment plus additional therapy effects on US population breast cancer mortality
Electronic health record embedded frailty index and outcomes among older adults receiving cancer chemotherapy
Volumes
2026 · 5232025 · 4242024 · 2942023 · 2422022 · 2722021 · 2732020 · 1962019 · 2232018 · 2252017 · 2812016 · 3402015 · 4142014 · 4972013 · 4782012 · 5282011 · 5402010 · 5732009 · 5022008 · 4882007 · 4942006 · 4992005 · 5802004 · 6072003 · 4942002 · 1252001 · 6342000 · 2661999 · 6591998 · 6051997 · 4991996 · 6711995 · 6731994 · 7281993 · 7401992 · 7771991 · 7391990 · 7691989 · 6741988 · 5011987 · 124
EUVIMED